Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1996-03-19
1997-08-12
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424469, 424470, 424486, 424487, 424488, 424494, 424496, 424497, 424498, 424501, 424502, 424495, A61K 922, A61K 926
Patent
active
056562950
ABSTRACT:
A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formulation provides a mean maximum plasma concentration of oxycodone from about 6 to about 60 ng/ml from a mean of about 2 to about 4.5 hours after administration, and a mean minimum plasma concentration from about 3 to about 30 ng/ml from about 10 to about 14 hours after repeated "q12h" (i.e., every 12 hour) administration through steady-state conditions. Another embodiment is directed to a method for substantially reducing the range in daily dosages required to control pain in substantially all patients by administering an oral solid controlled release dosage formulation comprising up to about 160 mg of oxycodone or a salt thereof, such that a mean maximum plasma concentration of oxycodone up to about 240 ng/ml from a mean of up to about 2 to about 4.5 hours after administration, and a mean minimum plasma concentration up to about 120 ng/ml from about 10 to about 14 hours after repeated "q12h" (i.e., every 12 hour) administration through steady-state conditions are achieved. Controlled release oxycodone formulations for achieving the above are also disclosed.
REFERENCES:
patent: 4862598 (1989-09-01), Oshlack
patent: 4990341 (1991-02-01), Goldie, et al.
patent: 5266331 (1993-11-01), Oshlack, et al.
Chasin Mark
Kaiko Robert Francis
Minogue John Joseph
Oshlack Benjamin
Euro-Celtique S.A.
Webman Edward J.
LandOfFree
Controlled release oxycodone compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release oxycodone compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release oxycodone compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-158315